← Back to Screener
Cronos Group Inc. Common Share (CRON)
Price$2.74
Value ScoreC
Growth ScoreB
Momentum ScoreB
Favorite Metrics
Price vs S&P 500 (26W)4.32%
Price vs S&P 500 (4W)10.96%
VGM Score57.59
Market Capitalization$1.46B
P/E Ratio (Annual)24.31x
All Metrics
P/CF (Annual)40.43x
Book Value / Share (Quarterly)$2.85
P/TBV (Annual)0.91x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)16.84%
Cash Flow / Share (Quarterly)$0.07
Price vs S&P 500 (YTD)-0.41%
Gross Margin (TTM)42.74%
Net Profit Margin (TTM)-1.14%
EPS (TTM)$-0.00
10-Day Avg Trading Volume0.25M
EPS Excl Extra (TTM)$-0.00
Revenue Growth (5Y)25.70%
EPS (Annual)$-0.02
ROI (Annual)-0.86%
Gross Margin (Annual)42.81%
Net Profit Margin (5Y Avg)-154.41%
Cash / Share (Quarterly)$2.18
P/E Basic Excl Extra (TTM)27.67x
Revenue Growth QoQ (YoY)40.13%
EPS Growth (5Y)-49.98%
P/E Normalized (Annual)24.31x
ROA (Last FY)-0.79%
Revenue Growth TTM (YoY)28.05%
EBITD / Share (TTM)$-0.03
ROE (5Y Avg)-9.62%
Operating Margin (TTM)-9.50%
Cash Flow / Share (Annual)$-0.00
P/B Ratio0.97x
P/B Ratio (Quarterly)0.89x
Net Income / Employee (Annual)$-15,100
EV / Revenue (TTM)1.40x
Net Interest Coverage (TTM)-44.46x
ROA (TTM)-0.15%
EPS Growth QoQ (YoY)127.85%
EV / EBITDA (TTM)722.55x
EPS Incl Extra (Annual)$-0.02
Current Ratio (Annual)19.59x
Quick Ratio (Quarterly)20.61x
3-Month Avg Trading Volume0.18M
52-Week Price Return47.51%
EV / Free Cash Flow (Annual)37.72x
P/E Incl Extra (TTM)27.67x
Revenue / Employee (TTM)$254,800
Tangible BV / Share (Quarterly)$2.83
P/S Ratio (Annual)7.13x
Asset Turnover (Annual)0.12x
52-Week High$4.66
Operating Margin (5Y Avg)-232.78%
EPS Excl Extra (Annual)$-0.02
CapEx CAGR (5Y)-5.94%
Tangible BV CAGR (5Y)-7.95%
26-Week Price Return12.24%
Quick Ratio (Annual)18.45x
13-Week Price Return9.38%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)21.87x
Enterprise Value$223.99M
Revenue / Share Growth (5Y)23.53%
Asset Turnover (TTM)0.14x
Book Value / Share Growth (5Y)-9.61%
Revenue / Employee (Annual)$234,200
Inventory Turnover (Annual)2.10x
Pretax Margin (Annual)-11.68%
Cash / Share (Annual)$2.18
3-Month Return Std Dev41.19%
Gross Margin (5Y Avg)14.22%
Net Income / Employee (TTM)$-2,900
ROE (Last FY)-0.86%
Net Interest Coverage (Annual)-0.43x
EPS Basic Excl Extra (Annual)$-0.02
P/FCF (TTM)38.44x
Receivables Turnover (TTM)6.17x
EV / Free Cash Flow (TTM)8.55x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-0.00
Receivables Turnover (Annual)5.92x
ROI (TTM)-0.17%
P/S Ratio (TTM)6.56x
Pretax Margin (5Y Avg)-146.04%
Revenue / Share (Annual)$0.38
Tangible BV / Share (Annual)$2.84
Forward P/E29.36x
Price vs S&P 500 (52W)23.14%
P/E Ratio (TTM)27.67x
Year-to-Date Return6.94%
5-Day Price Return-2.04%
EPS Normalized (Annual)$-0.02
ROA (5Y Avg)-9.20%
Net Profit Margin (Annual)-6.44%
Month-to-Date Return-2.04%
Cash Flow / Share (TTM)$-0.34
EBITD / Share (Annual)$-0.04
Operating Margin (Annual)-11.87%
LT Debt / Equity (Annual)0.06x
P/CF (TTM)26.91x
ROI (5Y Avg)-9.62%
P/E Excl Extra (TTM)27.67x
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$-0.00
P/TBV (Quarterly)0.90x
P/B Ratio (Annual)0.90x
Inventory Turnover (TTM)2.19x
Pretax Margin (TTM)-3.92%
Book Value / Share (Annual)$2.87
Price vs S&P 500 (13W)1.12%
Net Margin Growth (5Y)-62.81%
Beta1.43x
P/FCF (Annual)183.84x
Revenue / Share (TTM)$0.42
ROE (TTM)-0.17%
52-Week Low$2.54
vGradeC
gGradeB
mGradeB
vgmGradeC
Show chart for
Analyst Recommendations
Mar 2026
Apr 2026
May 2026
Jun 2026
4.11
4.11
4.11
4.11
Industry Peers — Pharmaceutical Preparations(17)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
CRONCronos Group Inc. Common Share | C | B | B | $2.74 |
| DFTXDefinium Therapeutics, Inc. Common Shares | — | — | A | $23.55 |
| TLRYTilray Brands, Inc. Common Stock | B | B | D | $4.94 |
| CGCCanopy Growth Corporation Common Shares | C | D | C | $1.03 |
| USNAUSANA Health Sciences Inc | B | D | C | $18.03 |
| NAGENiagen Bioscience, Inc. Common Stock | C | B | D | $3.45 |
| SNDLSundial Growers Inc. Common Shares | A | C | C | $1.42 |
| ACBAurora Cannabis Inc. Common Shares | B | C | C | $3.38 |
| MDWDMediWound Ltd. | D | F | D | $14.18 |
| FTLFFitLife Brands, Inc. Common Stock | B | C | D | $9.87 |
| BTMDBiote Corp. Class A Common Stock | B | D | C | $2.34 |
About
Cronos Group Inc is a cannabis company with operations in Canada, Israel, and other markets, generating the majority of its revenue from Canada. The company's brand portfolio includes Spinach, PEACE NATURALS, LIT, and Lord Jones. Cronos focuses on cannabis research, technology, and product development to drive competitive differentiation.